ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Xvivo Perfusion AB (PK)

Xvivo Perfusion AB (PK) (XVIPY)

7.1288
0.00
(0.00%)
終了 6月17日 5:00AM

Xvivo Perfusion AB (PK) (XVIPY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
7.1288
( - )
買値
4.99
売値
9.32
出来高
-
0.00 日の範囲 0.00
4.25 52 週間の範囲 7.70
時価総額
前日終値
7.1288
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 97,832
発行済株式数
31,499,470
配当利回り
PER
116.52
1 株当たり利益 (EPS)
2.34
歳入
834.53M
純利益
73.86M

Xvivo Perfusion AB (PK) について

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers K... Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Mölndal, Sweden
設立
1998
Xvivo Perfusion AB (PK) is listed in the sector of the その他OTC with ticker XVIPY. The last closing price for Xvivo Perfusion AB (PK) was US$7.13. Over the last year, Xvivo Perfusion AB (PK) shares have traded in a share price range of US$ 4.25 to US$ 7.70.

Xvivo Perfusion AB (PK) currently has 31,499,470 shares in issue. The market capitalisation of Xvivo Perfusion AB (PK) is US$224.55 million. Xvivo Perfusion AB (PK) has a price to earnings ratio (PE ratio) of 116.52.

XVIPY 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1007.12887.12887.128820507.1288DR
4007.12887.12887.128820507.1288DR
120.788812.44164037856.347.12886.345137.1288DR
262.528854.97391304354.67.12884.62567.05113814DR
52-0.4712-6.27.67.74.252276.13560208DR
1560.888814.24358974366.2412.974.253309.50529166DR
2603.128878.22412.9743608.86607224DR

XVIPY - Frequently Asked Questions (FAQ)

What is the current Xvivo Perfusion AB (PK) share price?
The current share price of Xvivo Perfusion AB (PK) is US$ 7.1288
How many Xvivo Perfusion AB (PK) shares are in issue?
Xvivo Perfusion AB (PK) has 31,499,470 shares in issue
What is the market cap of Xvivo Perfusion AB (PK)?
The market capitalisation of Xvivo Perfusion AB (PK) is USD 224.55M
What is the 1 year trading range for Xvivo Perfusion AB (PK) share price?
Xvivo Perfusion AB (PK) has traded in the range of US$ 4.25 to US$ 7.70 during the past year
What is the PE ratio of Xvivo Perfusion AB (PK)?
The price to earnings ratio of Xvivo Perfusion AB (PK) is 116.52
What is the cash to sales ratio of Xvivo Perfusion AB (PK)?
The cash to sales ratio of Xvivo Perfusion AB (PK) is 10.3
What is the registered address of Xvivo Perfusion AB (PK)?
The registered address for Xvivo Perfusion AB (PK) is Gemenskapens gata 9, Mölndal, Västra Götaland County, 431 53
What is the Xvivo Perfusion AB (PK) website address?
The website address for Xvivo Perfusion AB (PK) is www.xvivogroup.com

XVIPY 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock